Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia-- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for authorization with MHRA, with additional filings in process-- All modules required for Australian regulatory evaluation, including Quality/ CMC data, are now complete
Finally here we have Novavax
Aussie mRNA manufacturer 2b DECIDED this week, page-22
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $51.55M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $20.70K | 174.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 543275 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 65395 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| IDT (ASX) Chart |